201 related articles for article (PubMed ID: 12620440)
1. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.
Ghazeeri G; Kutteh WH; Bryer-Ash M; Haas D; Ke RW
Fertil Steril; 2003 Mar; 79(3):562-6. PubMed ID: 12620440
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
3. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
Mohsen IA
Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
[TBL] [Abstract][Full Text] [Related]
5. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
6. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone.
Vandermolen DT; Ratts VS; Evans WS; Stovall DW; Kauma SW; Nestler JE
Fertil Steril; 2001 Feb; 75(2):310-5. PubMed ID: 11172832
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
[TBL] [Abstract][Full Text] [Related]
8. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
[TBL] [Abstract][Full Text] [Related]
9. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Shobokshi A; Shaarawy M
J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Clin Endocrinol Metab; 2005 Jan; 90(1):60-5. PubMed ID: 15483106
[TBL] [Abstract][Full Text] [Related]
11. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.
Kocak M; Caliskan E; Simsir C; Haberal A
Fertil Steril; 2002 Jan; 77(1):101-6. PubMed ID: 11779598
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Cataldo NA; Abbasi F; McLaughlin TL; Basina M; Fechner PY; Giudice LC; Reaven GM
Hum Reprod; 2006 Jan; 21(1):109-20. PubMed ID: 16155076
[TBL] [Abstract][Full Text] [Related]
13. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
[TBL] [Abstract][Full Text] [Related]
14. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.
Sahin Y; Yirmibeş U; Keleştimur F; Aygen E
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):214-20. PubMed ID: 15063963
[TBL] [Abstract][Full Text] [Related]
15. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial.
Parsanezhad ME; Alborzi S; Motazedian S; Omrani G
Fertil Steril; 2002 Nov; 78(5):1001-4. PubMed ID: 12413984
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance.
Lv L; Liu Y
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):480-2. PubMed ID: 15641698
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
[TBL] [Abstract][Full Text] [Related]
18. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome.
El Sharkwy IA; Abd El Aziz WM
Int J Gynaecol Obstet; 2019 Oct; 147(1):59-64. PubMed ID: 31273783
[TBL] [Abstract][Full Text] [Related]
20. Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive?
Abu Hashim H; El-Shafei M; Badawy A; Wafa A; Zaglol H
Arch Gynecol Obstet; 2011 Aug; 284(2):503-7. PubMed ID: 21594601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
